Pseudoxanthoma elasticum: Molecular genetics and putative pathomechanisms

Journal of Investigative Dermatology

Volumn 130, Issue 3, 2010, Pages 661-670

  Uitto, Jouni ^a   Li, Qiaoli ^a   Jiang, Qiujie ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCC6 PROTEIN; BEVACIZUMAB; CARRIER PROTEIN; DNA; FETUIN A; FIBRILLIN 1; FIBRILLIN 2; GENE PRODUCT; GLUTATHIONE; MTRAIX GLA PROTEIN; MULTIDRUG RESISTANCE PROTEIN 6; PROTEIN; UNCLASSIFIED DRUG; VITAMIN K GROUP;

CARBOXYLATION; CARDIOVASCULAR RISK; CIRCULATION; CONNECTIVE TISSUE CELL; DNA MODIFICATION; DRUG EFFICACY; ENVIRONMENTAL FACTOR; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC COUNSELING; GENETIC TRANSCRIPTION; GENOTYPE; HETEROZYGOSITY; HUMAN; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; MINERALIZATION; MOLECULAR GENETICS; MOLECULAR THERAPY; MORBIDITY; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NONSENSE MUTATION; OPHTHALMOLOGY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PSEUDOXANTHOMA ELASTICUM; REVIEW; SKIN MANIFESTATION; SUBRETINAL NEOVASCULARIZATION; VITAMIN K DEFICIENCY;

EID: 76649133303     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.411     Document Type: Article

References (98)

1. Aherrahrou Z, Doegring LC, Ehlers E-M et al. (2008) An alternative splice variant in Abcc6, the gene causing dystrophic calcification, leads to protein deficiency in C3H/ He Mice. J Biol Chem 283:7608-7615
2. Baccarani-Contri M, Bacchelli B, Boraldi F et al. (2001) Characterization ofpseudoxanthoma elasticum-like lesions in the skin of patients with beta-thalassemia. J Am Acad Dermatol 44:33-39
3. Balzer F (1884) Recherches sur les charactères anatomiques du xanthelasma. Arch Physiol 4:65-80
4. Belinsky MG, Chen ZS, Shchaveleva I et al. (2002) Characterization of the drug resis tance and transport properties of multi-drug resistance protein 6 (MRP6, ABCC6). Cancer Res 62:6172-6177
5. Belinsky MG, Kruh GD (1999) MOAT-E (ARA) is a full length MRP/cMOAT subfamily transporter expressed in kidney and liver. Br J Cancer 80:1342-1349
6. Bercovitch L, Leroux T, Terry S et al. (2004) Pregnancy and obstetrical outcomes in pseu-doxanthoma elasticum. Br J Dermatol 151: 1011-1018
7. Bergen AA, Plomp AS, Schuurman EJ et al. (2000) Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet 25:228-231
8. Berkner KL (2005) The vitamin K-dependent carboxylase. Ann Rev Nutr 25:127-149
9. Borst P, Elferink RO (2002) Mammalian ABC transporters in health and disease. Annu Rev Biochem 71:537-592
10. Borst P, van de Wetering K, Schlingemann R (2008) Does the absence of ABCC6 (Multi-drug Resistance Protein 6) in patients with pseudoxanthoma elasticum prevent the liver from providing sufficient vitamin K to the periphery? Cell Cycle 7:1575-1579
11. Cai L, Struk B, Adams MD et al. (2000) A 500-kb region on chromosome 16p13.1 contains the pseudoxanthoma elasticum locus: high-resolution mapping and genomic structure. J Mol Med 78:36-46
12. Capla JM, Ceradini DJ, Tepper OM et al. (2006) Skin graft vascularization involves precisely regulated regression and replacement of endothelial cells through both angiogenesis and vasculogenesis. Plast Reconstr Surg 117:836-844
13. Carlborg U (1944) Study of circulatory disturbances, pulse wave velocity and pressure pulses in large arteries in cases of pseudox-anthoma elasticum and angioid streaks: a contribution to the knowledge of function of the elastic tissue and the smooth muscles in larger arteries. Acta Med Scand 151:1-209
14. Chassaing N, Martin L, Bourthoumieu S et al. (2007) Contribution of ABCC6 genomic rearrangements to the diagnosis of pseudox-anthoma elasticum in French patients. Hum Mutat 28:1046
15. Chassaing N, Martin L, Calvas P et al. (2005) Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations. J Med Genet 42:881-892
16. Chassaing N, Martin L, Mazereeuw J et al. (2004) Novel ABCC6 mutations in pseudoxanthoma elasticum. J Invest Dermatol 122:608-613
17. Chauffard MA (1889) Xanthelasma disséminé et symmétrique sans insufficiance hépatique. Bull Soc Med Hop Paris 6:412-419
18. Christiano AM, Lebwohl MG, Boyd CD et al. (1992) Workshop on pseudoxanthoma elas-ticum: molecular biology and pathology of the elastic fibers. Jefferson Medical College, Philadelphia, Pennsylvania. J Invest Derma-tol 99:660-663
19. Darier J (1896) Pseudo-xanthome élastique. IIIe Congrès Intern de Dermat de Londres 5:289-295
20. Finger RP, Charbel Issa P, Ladewig MS et al. (2009) Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic ap proaches. Surv Ophthalmol 54:272-285
21. Fülöp K, Barna L, Symmons O et al. (2009) Clustering of disease-causing mutations on the domain-domain interfaces of ABCC6. Biochem Biophys Res Commun 379:706-709
22. Georgalas I, Papaconstantinou D, Koutsandrea C et al. (2009) Angioid streaks, clinical course, complications, and current therapeutic management. Ther Clin Risk Manag 5:81-89
23. Gheduzzi D, Boraldi F, Annovi G et al. (2007) Matrix Gla protein is involved in elastic fiber calcification in the dermis of pseudoxantho-ma elasticum patients. Lab Invest 87: 998-1008
24. Goral V, Demir D, Tuzun Y et al. (2007) Pseudoxanthoma elasticum, as a repetitive upper gastrointestinal hemorrhage cause in a pregnant woman. World J Gastroenterol 13:3897-3899
25. Gorgels TG, Hu X, Scheffer GL et al. (2005) Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum Mol Genet 14:1763-1773
26. Gronblad E (1929) Angioid streaks-pseudoxanthoma elasticum. Acta Ophthalmol 7:329
27. Hamlin N, Beck K, Bacchelli B et al. (2003) Acquired pseudoxanthoma elasticum-like syndrome in beta-thalassaemia patients. Br J Haematol 122:852-854
28. Hendig D, Arndt M, Szliska C et al. (2007) SPP1 promoter polymorphisms: identification of the first modifier gene for pseudoxanthoma elasticum. Clin Chem 53:829-836
29. Hendig D, Schulz V, Arndt M et al. (2006) Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin Chem 52:227-234
30. Hu X, Plomp A, Gorgels T et al. (2004) Efficient molecular diagnostic strategy for ABCC6 in pseudoxanthoma elasticum. Genet Test 8:292-300
31. Ilias A, Urban Z, Seidl TL et al. (2002) Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J Biol Chem 277: 16860-16867
32. Jahnen-Dechent W, Schinke T, Trindl A et al. (1997) Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 272: 31496-31503
33. /~). J Invest Dermatol. (in press)
34. Jiang Q, Endo M, Dibra F et al. (2009) Pseudoxanthoma elasticum is a metabolic disease. J Invest Dermatol 129:348-354
35. Jiang Q, Li Q, UittoJ (2007) Aberrant mineralization of connective tissues in a mouse model of pseudoxanthoma elasticum: systemic and local regulatory factors. J Invest Dermatol 127:1392-4102
36. Jiang Q, Matsuzaki Y, Li K et al. (2006) Transcriptional regulation and characterization of the promoter region of the human ABCC6 gene. J Invest Dermatol 126:325-335
37. Jiang Q, Oldenburg R, Otsuru S et al. (2010a) Parabiotic heterogenetic pairing of Abcc6-/-; Rag1-/-mice and their wild-type counterparts halts ectopic mineralization in a murine model of pseudoxanthoma elasticum. Am J path (in press)
38. Jiang Q, Uitto J (2006) Pseudoxanthoma elasticum: a metabolic disease? J Invest Dermatol 126:1440-1441
39. Klement JF, Matsuzaki Y, Jiang Q-J et al. (2005) Targeted ablation of the ABCC6 gene results in ectopic mineralization of connective tissues. Mol Cell Biol 25:8299-8310
40. Kornet L, Bergen AA, Hoeks AP et al. (2004) In patients with pseudoxanthoma elasticum a thicker and more elastic carotid artery is associated with elastin fragmentation and proteoglycans accumulation. Ultrasound Med Biol 30:1041-1048
41. Kovach JL, Schwartz SG, Hickey M et al. (2009) Thirty-two month follow-up of successful treatment of choroidal neovascularization from angioid streaks with intravitreal bev-acizumab. Ophthalmic Surg Lasers Imaging 40:77-79
42. LaRusso J, Jiang Q, Li Q et al. (2008) Ectopic mineralization of connective tissue in Abcc6" mice: effects of dietary modifications and a phosphate binder-a preliminary study. Exp Dermatol 17:203-7
43. LaRusso J, Li Q, Jiang Q et al. (2009) Elevated dietary magnesium prevents connective tissue mineralization in a mouse model of pseudoxanthoma elasticum (Abcc6). J Invest Dermatol 129:1388-1394
44. Le Saux O, Beck K, Sachsinger C et al. (2002) Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa. Hum Genet 111:331-338
45. Le Saux O, Bunda S, VanWart CM et al. (2006) Serum factors from pseudoxanthoma elasticum patients alter elastic fiber formation in vitro. J Invest Dermatol 126:1497-1505
46. Le Saux O, Urban Z, Goring HH et al. (1999) Pseudoxanthoma elasticum maps to an 820-kb region of the p13.1 region of chromosome 16. Genomics 62:1-10
47. Le Saux O, Urban Z, Tschuch C et al. (2000) Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat Genet 25:223-227
48. Lebwohl M, Schwartz E, Lemlich G et al. (1993) Abnormalities of connective tissue components in lesional and non-lesional tissue of patients with pseudoxanthoma elasticum. Arch Dermatol Res 285:121-126
49. /~). Biochem Biophys Res Commun 364:208-213
50. Li Q, Jiang Q, Pfendner E et al. (2009a) Pseudoxanthoma elasticum: clinical pheno-types, molecular genetics and putative pathomechanisms. Exp Derm 18:1-11
51. Li Q, Grange DK, Armstrong NL et al. (2009b) Mutations in the GGCX and ABCC6 genes in a family with pseudoxanthoma elasticum-like phenotypes. J Invest Dermatol 129: 553-563
52. Li Q, Jiang Q, Uitto J (2008) Pseudoxanthoma elasticum: oxidative stress and antioxidant diet in a mouse model (Abcc6). J Invest Dermatol 128:1160-1164
53. Li Q, LaRusso J, Grand-Pierre AE et al. (2010) Magnesium carbonate-containing phosphate binder prevents connective tissue mineralization in Abcc6-/-mice-potential for treatment of pseudoxanthoma elasticum. Clinical Trans-lational Science (in press)
54. Li Q, Schurgers LJ, Smith ACM et al. (2009c) Co-existent pseudoxanthoma elasticum and vitamin K-dependent coagulation factor deficiency. Am J Pathol 174:534-539
55. Li Q, Uitto J (2010) The mineralization phenotype in Abcc6-/-mice is affected by Ggcx gene deficiency and genetic background \-a model for pseudoxanthoma elasticum. J Mol Med. (in press; PMID: 19784827).
56. Luo G, Ducy P, McKee MD et al. (1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386:78-81
57. Martin L, Chassaing N, Delaite D et al. (2007) Histological skin changes in heterozygote carriers of mutations in ABCC6, the gene causing pseudoxanthoma elasticum. J Eur Acad Dermatol Venereol 21:368-373
58. Martin L, Mâitre F, Bonicel P et al. (2008) Heterozygosity for a single mutation in the ABCC6 gene may closely mimic PXE: consequences of this phenotype overlap for the definition of PXE. Arch Dermatol 144:301-306
59. Mendelsohn G, Bulkley BH, Hutchins GM (1978) Cardiovascular manifestations of pseudox-anthoma elasticum. Arch Pathol Lab Med 102:298-302
60. Miksch S, Lunsden A, Guenther UP et al. (2005) Molecular genetics of pseudoxanthoma elas-ticum: type and frequency of mutations in ABCC6. Hum Mutat 26:235-248
61. Naorui M, Boisseau C, Bonicel P et al. (2009) Manifestations of pseudoxanthoma elasti-cum in childhood. Br J Dermatol 161:635-639
62. Neldner KH (1988) Pseudoxanthoma elasticum. Clin Dermatol 6:1-159
63. Pasquali-Ronchetti I, Garcia-Fernandez MI, Bor-aldi F et al. (2006) Oxidative stress in fibroblasts from patients with pseudoxantho-ma elasticum: possible role in the pathogen-esis of clinical manifestations. J Pathol 208:54-61
64. Passi A, Albertini R, Baccarani Contri M et al. (1996) Proteoglycan alterations in skin fibro-blast cultures from patients affected with pseudoxanthoma elasticum. Cell Biochem Funct 14:111-120
65. Pfendner E, Uitto J, Gerard GF et al. (2008) Pseudoxanthoma elasticum: genetic diagnostic markers. Exp Opinion Med Diagn 2:1-17
66. Pfendner EG, Vanakker OM, Terry SF et al. (2007) Mutation detection in the ABCC6 gene and genotype-phenotype analysis in a large international case series affected by pseudox-anthoma elasticum. J Med Genet 44:621-628
67. Plomp AS, Hu X, De Jong PT et al. (2004) Does autosomal dominant pseudoxanthoma elas-ticum exist? Am J Med Genet 126:403-412
68. Pope FM (1975) Historical evidence for the genetic heterogeneity of pseudoxanthoma elasticum. Br J Dermatol 92:493-509
69. Pulkkinen L, Nakano A, Ringpfeil F et al. (2001) Identification of ABCC6 pseudogenes on human chromosome 16p: implications for mutation detection in pseudoxanthoma elas-ticum. Hum Genet 109:356-365
70. Quaglino D, Boraldi F, Barbieri D et al. (2000) Abnormal phenotype of in vitro dermal fibroblasts from patients with pseudoxantho-ma elasticum (PXE). Biochim Biophys Acta 1501:51-62
71. Quaglino D, Sartor L, Garbisa S et al. (2005) Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 de-gradative potential. Biochim Biophys Acta 1741:42-47
72. Ramsay M, Greenberg T, Lombard Z et al. (2009) Spectrum of genetic variation at the ABCC6 locus in South Africans: pseudoxanthoma elasticum patients and healthy individuals. J Dermatol Sci 54:198-204
73. Raybould MC, Birley AJ, Moss C et al. (1994) Exclusion of an elastin gene (ELN) mutation as the cause of pseudoxanthoma elasticum (PXE) in one family. Clin Genet 45:48-51
74. Renie WA, Pyeritz RE, Combs J et al. (1984) Pseudoxanthoma elasticum: high calcium intake in early life correlates with severity. Am J Med Genet 19:235-244
75. Ringpfeil F, Lebwohl MG, Christiano AM et al. (2000) Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci USA 97:6001-6006
76. Ringpfeil F, Nakano A, Uitto J et al. (2001) Compound heterozygosity for a recurrent 16.5-kb Alu-mediated deletion mutation and single-base-pair substitutions in the ABCC6 gene results in pseudoxanthoma elasticum. Am J Hum Genet 68:642-652
77. Ringpfeil F, McGuigan K, Fuchsel L et al. (2006) Pseudoxanthoma elasticum is a recessive disease characterized by compound hetero-zygosity. J Invest Dermatol 126:782-786
78. Ryan LM (2001) The ank gene story. Arthritis Res 3:77-79
79. Sakata S, Su JC, Robertson S et al. (2006) Varied presentations of pseudoxanthoma elasticum in a family. J Pediatr Child Health 42:817-820
80. Sakuraoka K, Tajima S, Nishikawa T et al. (1994) Biochemical analyses of macromolecular matrix components in patients with pseudox-anthoma elasticum. J Dermatol 21:98-101
81. Sawa M, Gomi F, Tsujikawa M et al. (2009) Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioig streaks. Am J Ophthal-mol 148:584-90.e2.
82. Scheffer GL, Hu X, Pijnenborg AC et al. (2002) MRP6 (ABCC6) detection in normal human tissues and tumors. Lab Invest 82:515-518
83. Schön S, Schulz V, Prante C et al. (2006) Polymorphisms in the xylosyltransferase genes cause higher serum XT-I activity in patients with pseudoxanthoma elasticum (PXE) and are involved in a severe disease course. J Med Genet 43:745-749
84. Shearer MJ (2000) Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 3:433-438
85. Strandberg J (1929) Pseudoxanthoma elasticum. Z Haut Geschlechtskr 31:689-694
86. Struk B, Cai L, Zäch S et al. (2000) Mutations of the gene encoding the transmembrane transporter protein ABCC6 cause pseudoxantho-ma elasticum. J Mol Med 78:282-286
87. Szakács G, Váradi A, Ozvegy-Lacka C et al. (2008) The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ASME-Tox). Drug Discov Today 13:379-393
88. Tamai K, Kaneda Y, Uitto J (2009) Molecular therapies for heritable blistering diseases. Trends Mol Med 15:285-292
89. Tan WC, Rodeck CH (2008) Placental calcification in pseudoxanthoma elasticum. Ann Acad Med Singapaore 37:598-600
90. Trip MD, Smulders YM, Wegman JJ et al. (2002) Frequent mutation in the ABCC6 gene (R1141X) is associated with a strong increase in the prevalence of coronary artery disease. Circulation 106:773-775
91. Uitto J (2009) Progress in heritable skin diseases: translational implications of mutation analysis and prospects of molecular therapies. Act Derm Venereol 89:228-235
92. Uitto J, Pulkkinen L, Ringpfeil F (2001) Molecular genetics of pseudoxanthoma elasticum\-a metabolic disorder at the environment-genome interface? Trends Mol Med 7:13-17
93. Uitto J, Ringpfeil F (2007) Heritable diseases affecting the elastic fibers: cutis laxa, pseu-doxanthoma elasticum and related disorders. In: Principles and Practice of Genetics. (Rimoin DL, Connor JM, Pyeritz RE, and Korf BR, eds). Churchill Livingstone, Philadelphia. 5th ed 3647-3670
94. Vanakker OM, Martin L, Gheduzzi D et al. (2007) Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity. J Invest Dermatol 27:581-587
95. Vattikuti R, Towler DA (2004) Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 286:E686-96
96. Wiegand TW, Rogers AH, McCabe F et al. (2009) Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularization in patients with angioid streaks. Br J Ophthalmol 93: 47-51
97. Zarbock R, Hendig D, Szliska C et al. (2007) Pseudoxanthoma elasticum: genetic variations in antioxidant genes are risk factors for early disease onset. Clin Chem 53:1734-1740
98. Zarbock R, Hendig D, Szliska C et al. (2009) Vascular endothelial growth factor gene polymorphisms as prognostic markers for ocular manifestations in pseudoxanthoma elasticum. Hum Mol Genet 18:3344-3351